Transforming Viral Vector Manufacturing With Capillary Electrophoresis
Capillary electrophoresis (CE) is transforming viral vector manufacturing for next-generation biopharmaceuticals. Traditionally used for quality control, CE can now be used to profile viral proteins in AAV particles and examine genome integrity during production, thanks to novel sample preparation techniques.
In this webinar, our expert speakers will explore the different ways that CE is advancing biopharmaceutical development. They will also discuss how new reference standards are improving our understanding of genome and protein sizes in viral particles and how this impacts the development of viral vector-based therapies.
Attend this webinar to:
- See how CE is being utilized to profile viral proteins in AAV particles during manufacturing
- Discover how CE is instrumental in examining the genome integrity of viral particles throughout production
- Explore how the adoption of new reference standards is enhancing the understanding of genome and protein sizes during viral particle manufacturing
Speakers
Brought to you by
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
